Description
Structure & Identity
The GLOW kit supplies three structurally distinct peptides, each studied through its own mechanism. BPC-157 is a 15-amino-acid synthetic peptide sequence, most often discussed in angiogenesis and nitric-oxide-pathway research. TB-500 is the full-length, 43-residue acetylated form of thymosin beta-4. GHK-Cu is a copper-bound tripeptide (glycyl-histidyl-lysine complexed with copper(II)) studied for its redox chemistry as a copper carrier. Grouping them lets researchers work across three distinct signaling angles, angiogenic, cytoskeletal, and redox, in one set, while each peptide keeps its own structure and its own vial.
Research Background
The three peptides cover angiogenic, cytoskeletal, and redox-chemistry research threads.
- BPC-157 signaling. Studied for angiogenesis and nitric-oxide-pathway signaling [PMID: 30915550].
- TB-500 actin biology. An actin-sequestering protein tied to cell migration [PMID: 16099219].
- GHK-Cu oxidative stress. Studied for redox activity in oxidative-stress assays [PMID: 22666519].
- GHK-Cu gene-expression study. Extracellular-matrix-related gene-expression readouts in a rodent model [PMID: 25731775].
- Connective-tissue thread. GHK-Cu’s copper-carrier chemistry connects the kit to redox and metal-biology research.
These are research contexts, not approved uses, and the kit is intended for laboratory study.
Specifications
| Attribute | Value |
| Product type | Kit (three separate vials) |
| Vial 1 | BPC-157, 10 mg (CAS 137525-51-0, MW 1419.5 Da) |
| Vial 2 | TB-500 (thymosin beta-4 fragment), 10 mg (CAS 77591-33-4, MW 4963.55 Da) |
| Vial 3 | GHK-Cu (copper tripeptide), 50 mg (CAS 89030-95-5, MW ~404 Da) |
| Purity | ≥99% by reverse-phase HPLC (each) |
| Identity | Confirmed by ESI mass spectrometry |
| Physical form | Lyophilized powder |
| Storage | -20°C, protected from light |
| Solubility | Soluble in bacteriostatic or sterile water |
| Classification | Research use only |
Storage & Handling
Keep all three sealed vials frozen at -20°C and shielded from light until use. After preparation for your assay, store each solution at 2-8°C and use in your study within about two weeks. Warm a vial to room temperature before opening, and avoid repeated freeze-thaw cycles. GHK-Cu reconstitutes to a blue-tinged solution, which is normal for the copper complex.
Quality Assurance
All three peptides are produced under research-grade manufacturing controls and verified by an independent lab before release. Purity is measured by reverse-phase HPLC and identity by mass spectrometry, with testing carried out by third-party laboratories, including Janoshik Analytical and domestic US labs. Each vial ships with its own batch-specific certificate of analysis.
Frequently Asked Questions
What is in the GLOW Kit?
Three separate vials: BPC-157 10 mg, TB-500 10 mg, and GHK-Cu 50 mg. The kit is studied across angiogenesis/cytoskeletal signaling and copper-tripeptide redox research.
How is the GLOW Kit different from the GLOW blend?
The kit provides the three peptides as separate vials; the GLOW blend pre-combines them in one vial. The kit lets researchers handle each peptide independently.
Is TB-500 in this kit the “Ac-SDKP” fragment?
No. TB-500 is a fragment of thymosin beta-4. Ac-SDKP is a different peptide entirely and is not what TB-500 refers to.
Why is GHK-Cu’s solution blue?
The blue tint comes from the copper(II) ion carried by the GHK tripeptide, which is normal for a genuine GHK-Cu preparation.
Does each vial come with its own COA?
Yes. Each of the three peptides is tested separately and ships with its own batch-specific certificate of analysis.
Is the GLOW Kit FDA approved?
No. None of the components is FDA approved. The kit is a research-use-only preparation, not for human or veterinary use.
How should the kit be stored?
Keep all powders frozen at -20°C and protected from light until use. As with all lyophilized peptides, preparation should follow your lab’s own protocols.
How are the peptides verified?
Each is tested to ≥99% purity by reverse-phase HPLC with mass-spec identity confirmation by an independent lab.
